Vetter Pharma International GmbH

Vetter Pharma International GmbH

Sales markets: Western Europe | Asia | Australia | North America

About us

Vetter is a leading contract development and manufacturing organization (CDMO) that specializes in the aseptic filling of syringes, cartridges and vials. The company has extensive experience with biologics and other complex compounds, including monoclonal antibodies, peptides, interferons and vaccines. Collaborating with pharma/biotech clients worldwide, Vetter supports products from preclinical development through global market supply. Through its U.S. and European facilities, Vetter Development Service provides state-of-the-art support for early-stage products, with seamless transfer at Phase III to Vetter Commercial Manufacturing for large-scale production. The company offers state-of-the-art technology and innovative processes to promote product quality and maximize API yield.

Read more

Meet us at

9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain Visit us at stand 3C80 Book a meeting See our Exhibitor Profile

News about Vetter Pharma International GmbH

Vetter on new pathways to further develop the injection process

8 Jun 2018

Vetter on new pathways to further develop the injection process

Open Innovation Challenge to tackle how digital trends can be applied to enhance solutions for the injection of medicines.

Read more

6 Mar 2018

Vetter is a winner of the Fraunhofer clean manufacturing award CLEAN! 2018

Pharmaceutical service provider convinces jury with its innovative cleanroom technology V-CRT®

- Vetter comes in 3rd at CLEAN! 2018
- Fraunhofer IPA honors innovative groundbreaking developments in clean technology
- The holistic and innovative manufacturing technology V-CRT® from Vetter convinces an expert jury with its aseptic safety.

Read more

28 Sep 2017

Vetter lays the foundation for a state-of-the-art administration building

At a cornerstone ceremony, Vetter officially signaled the start of a project for the creation of a new administration building at its Ravensburg Schuetzenstrasse site. Scheduled to be completed by the middle of 2019, the new building is part of an ongoing investment strategy designed to further develop Vetter sites and make available additional manufacturing capacities.

Read more

25 Jan 2017

Vetter starts operations in its Center for Visual Inspection and Logistics

Vetter, a leading global Contract Development and Manufacturing Organization (CDMO) for development, aseptic filling and final packaging of injectables, has announced today that it has begun operations in its expanded Visual Inspection and Logistics Center located in Ravensburg. The enlargement, in which the company invested approximately 100 million euros ($107 million), bundles capacity for final product inspection and logistics in one cutting-edge site. By finalizing the second construction stage of the site that was initially put into operation five years ago, the CDMO now offers more than double the capacity for state-of-the-art quality control, cold-storage and room-temperature storage. Given the increasing industry-specific requirements emanating from customer and regulatory side, the company now provides even more efficient and flexible supply chain processes. 

Read more


Vetter Packaging Solutions

Delivering your product’s potential

catalog | 2018-03-06
Vetter Commercial Manufacturing

Delivering results across the production chain

catalog | 2018-03-06
Vetter Corporate Brochure

From clinical development to commercial production

catalog | 2018-03-06
Vetter Development Service

Supporting your compounds success

catalog | 2018-03-06
Vetter Pharma International GmbH

Contact information




View all contact information